Global Delivery System for Gene Therapy Market Growth (Status and Outlook) 2025-2031

The global Delivery System for Gene Therapy market size is predicted to grow from US$ 4899 million in 2025 to US$ 13330 million in 2031; it is expected to grow at a CAGR of 18.2% from 2025 to 2031.

Delivery system in gene therapy refer to the technologies and methods for safely and effectively delivering therapeutic genes or gene editing tools to target cells or tissues. The delivery system is the key to the success of gene therapy because it determines whether the gene can accurately reach the target location and play a therapeutic role.

United States market for Delivery System for Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Delivery System for Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Delivery System for Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Delivery System for Gene Therapy players cover Creative Biogene, Thermo Fisher Scientific, Creative Biolabs, Lupagen, Biocompare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Delivery System for Gene Therapy Industry Forecast” looks at past sales and reviews total world Delivery System for Gene Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Delivery System for Gene Therapy sales for 2025 through 2031. With Delivery System for Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Delivery System for Gene Therapy industry.

This Insight Report provides a comprehensive analysis of the global Delivery System for Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Delivery System for Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Delivery System for Gene Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Delivery System for Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Delivery System for Gene Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Delivery System for Gene Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Viral vectors
Non-viral vectors

Segmentation by Application:
Cancer Treatment
Infectious Disease Treatment
Genetic Disease Treatment
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biogene
Thermo Fisher Scientific
Creative Biolabs
Lupagen
Biocompare
Agilent
Bio-Techne
Revvity

Please note: The report will take approximately 2 business days to prepare and deliver.